Current Cancer Therapy Reviews
Title:Preface
Volume: 13 Issue: 1
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
Zaenker S. Kurt , Preface, Current Cancer Therapy Reviews 2017; 13 (1) . https://dx.doi.org/10.2174/157339471301170829120019
DOI https://dx.doi.org/10.2174/157339471301170829120019 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue "Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics" aims to explore cutting-edge developments and innovative strategies in the field of lipid nanoparticle (LNP) technology, particularly focusing on its application in mRNA delivery. This topic has gained unprecedented attention and urgency in the wake of the COVID-19 ...read more
Current Progress in Protein Degradation and Cancer Therapy
Targeted Protein Degradation is gaining momentum in cancer therapy; it facilitates targeting undruggable proteins, overcomes cancer resistance, and avoids undesirable side effects. Thus small molecule degraders have emerged as novel therapeutic strategies. Targeted protein degradation (TPD), the process of eliminating a protein of interest holds a great promise for the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets Synthesis of Graphene Oxide-Silver Nanoparticle Nanocomposites: An Efficient Novel Antibacterial Agent
Current Nanoscience Chemistry and Biology of Landomycins, an Expanding Family of Polyketide Natural Products
Mini-Reviews in Medicinal Chemistry Recent Developments in Patents Targeting Toll-Like Receptor Genes
Recent Patents on DNA & Gene Sequences Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue
Current Pharmaceutical Biotechnology The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Anti-Cancer Agents in Medicinal Chemistry Estrogen Receptor Signaling: Impact on Cell Functions
Current Signal Transduction Therapy Polyethyleneimine-Based Nanocarriers for Gene Delivery
Current Pharmaceutical Design Cytokine Gene Transfer into Dendritic Cells for Cancer Treatment
Current Gene Therapy Drug Interactions with Normal and TEN Epidermal Keratinocytes
Current Drug Safety Patented Biomarkers for the Early Detection of Ovarian Cancer
Recent Patents on Biomarkers Challenges in the Management of Paediatric Febrile Neutropenia
Current Pediatric Reviews Rational Identification of Enoxacin as a Novel V-ATPase-Directed Osteoclast Inhibitor
Current Protein & Peptide Science Editorial [ Anti-Angiogenesis Agents Executive Editor: Cezary Marcinkiewicz ]
Current Pharmaceutical Design Identifying and Validating Oncology Therapeutic Targets in the Post- Genomics Era
Current Genomics Mechanisms of Cytotoxicity of Anticancer Titanocenes
Anti-Cancer Agents in Medicinal Chemistry Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
Current Topics in Medicinal Chemistry Targeting Heat Shock Proteins in Tauopathies
Current Alzheimer Research Anti-Angiogenic Approaches to Malignant Gliomas
Current Cancer Drug Targets Intravesical Drug Delivery into the Bladder to Treat Cancers
Current Drug Delivery